Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of
Por um escritor misterioso
Last updated 22 outubro 2024
Background Combination of chemotherapies (fluoropirimidines, oxaliplatin and irinotecan) with biologic drugs (bevacizumab, panitumumab, cetuximab) have improved clinical responses and survival of metastatic colorectal cancer (mCRC). However, patients’ selection thorough the identification of predictive factors still represent a challange. Cetuximab (Erbitux®), a chimeric monoclonal antibody binding to the Epidermal Growth Factor Receptor (EGFR), belongs to the Immunoglobulins (Ig) grade 1 subclass able to elicite both in vitro and in vivo the Antibody-Dependent Cell-mediated Cytotoxicity (ADCC). ADCC is the cytotoxic killing of antibody-coated target cells by immunologic effectors. The effector cells express a receptor for the Fc portion of these antibodies (FcγR); genetic polymorphisms of FcγR modify the binding affinity with the Fc of IgG1. Interestingly, the high-affinity FcγRIIIa V/V is associated with increased ADCC in vitro and in vivo. Thus, ADCC could partially account for cetuximab activity. Methods/design CIFRA is a single arm, open-label, phase II study assessing the activity of cetuximab in combination with irinotecan and fluorouracile in FcγRIIIa V/V patients with KRAS, NRAS, BRAF wild type mCRC. The study is designed with a two-stage Simon model based on a hypothetical higher response rate (+ 10%) of FcγRIIIa V/V patients as compared to previous trials (about 60%) assuming ADCC as one of the possible mechanisms of cetuximab action. The test power is 95%, the alpha value of the I-type error is 5%. With these assumptions the sample for passing the first stage is 14 patients with > 6 responses and the final sample is 34 patients with > 18 responses to draw positive conclusions. Secondary objectives include toxicity, responses’ duration, progression-free and overall survival. Furthermore, an associated translational study will assess the patients’ cetuximab-mediated ADCC and characterize the tumor microenvironment. Discussion The CIFRA study will determine whether ADCC contributes to cetuximab activity in mCRC patients selected on an innovative immunological screening. Data from the translational study will support results’ interpretation as well as provide new insights in host-tumor interactions and cetuximab activity. Trial registration The CIFRA trial (version 0.0, June 21, 2018) has been registered into the NIH-US National Library of Medicine, ClinicalTrials.gov database with the identifier number ( NCT03874062 ).
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in
Phase II study of S-1-based sequential combination chemotherapy
Therapeutic strategy in unresectable metastatic colorectal cancer
Cetuximab and Chemotherapy as Initial Treatment for Metastatic
Colorectal Tumor Cells Treated with 5-FU, Oxaliplatin, Irinotecan
CHEMORADIOTHERAPY FOR COLORECTAL CANCER
A) Preferred first-line treatment for patients with metastatic
Comparison of irinotecan and oxaliplatin as the first-line
Optimising the use of cetuximab in the continuum of care for
PDF) Cetuximab in combination with irinotecan/5-fluorouracil
Full article: Cetuximab in the treatment of metastatic colorectal
Cetuximab in combination with weekly 5-fluorouracil/folinic acid
EPIC: phase III trial of cetuximab plus irinotecan after
BRAF mCRC, HCP
Frontiers Distinguishing Features of Cetuximab and Panitumumab
Recomendado para você
-
Toxic - Katy Perry Chords<<22 outubro 2024Pin by Becca Wilson-Summerford on Ukulele Stuff22 outubro 2024Divo Pereira 2 álbuns da Discografia no Cifra Club22 outubro 2024Toxic Holocaust22 outubro 2024Super Partituras - Toxicity (System of a Down), sem cifra22 outubro 2024Super Partituras - The Hook Up (Britney Spears, Christopher22 outubro 2024Toxic Chemicals We Consume Without Knowing It22 outubro 20243 Distribution map of the nine toxic species of the genus22 outubro 2024Toxic - BoyWithUke, ukulele chords22 outubro 2024Application Potentiality of Delayed Luminescenc in Medicine22 outubro 2024você pode gostar
-
Seth Rollins Addresses Becky Lynch's NXT Championship Win22 outubro 2024
-
MEI digital: veja como emitir suas DAS pelo app do governo22 outubro 2024
-
Valentine's Day - BattleBLAST22 outubro 2024
-
Cute cat huge love heart cartoon vector icon illustration animal isolated 18599102 Vector Art at Vecteezy22 outubro 2024
-
text #font Part 1 of telling color fonts for #plsdonate if u guys22 outubro 2024
-
Donkey Kong Country: Tropical Freeze: Nintendo Selects Wii U Game22 outubro 2024
-
Reiniciar o turismo, precisa-se!22 outubro 2024
-
Big Eyes Smart Mouth: Vampire Hunter D: Bloodlust (2001) - Psycho22 outubro 2024
-
Hard Mode Sans Sprites by ImXR24 on DeviantArt22 outubro 2024
-
Tweet You Retweeted Phil Spencer Had good calls this week with leaders at Sony. I confirmed22 outubro 2024
© 2014-2024 faktorgumruk.com. All rights reserved.